Navigation Links
China Heparin Industry Report, 2015-2018
Date:12/29/2015

NEW YORK, Dec. 29, 2015 /PRNewswire/ -- As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and the improved standards for heparin export pulled down the export volume of China's heparin API during 2011-2013. From 2014 onwards, China has seen the export of heparin and its salts warm up. From January to October of 2015, China exported 123.2 tons of heparin and its salts, higher than 106.7 tons in the whole 2014; however, the average export price fell 30.7% year on year to USD3,945.6 / ton.

The major global heparin API suppliers, including Hepalink, Nanjing King-friend, Dongcheng Biochemicals and Qianhong Bio-pharma generated the combined capacity of over 20 trillion units in 2014; also, they have been among the top 4 heparin exporters in China for many years, together accounting for over 70% of China's total heparin exports.

Along with the intensified heparin API supply capacity and raised product grades, Chinese heparin preparation market size is constantly expanding, reaching about RMB5 billion in 2014. In April 2015, Ministry of Human Resources and Social Security of the People's Republic of China issued Circular on Adjusting and Standardizing Some Drugs Listed in Drug Catalog of National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance to contain "enoxaparin sodium injection", "dalteparin sodium injection" and "nadroparin calcium injection" in the aforementioned catalog (previously only included in the medical insurance of some provinces and cities). This move will undoubtedly stimulate the consumption of heparin preparations in China, especially low molecular weight heparin preparations. Chinese heparin preparation market size is expected to jump 27.9% year on year to RMB6.38 billion in 2015.

Based on the corporate development and positive prospects of heparin products, Hepalink, Nanjing King-friend, Dongcheng Biochemicals, Qianhong Bio-pharma, Changshan Biochemical Pharmaceutical and other companies have been either deploying or improving low molecular weight heparin API and preparation industries in recent years.

Nanjing King-friend has consistently ranked second in Chinese heparin API export market in recent years, and boasts the most diversified low molecular weight heparin products. In 2014, the company produced and sold about 4 trillion units of heparin API. Meanwhile, it received new drug certifications on enoxaparin sodium API and preparations, dalteparin sodium API and preparations. It obtained an approval on nadroparin calcium API and preparations on May 13, 2015. In addition, Nanjing King-friend has a production line involved with 3000kg/a low molecular weight heparin (1000kg/a enoxaparin sodium, 1000kg/a dalteparin, 1000kg/a nadroparin calcium) under construction; the project is expected to be completed and put into operation in December 2017.

As one of the main suppliers of heparin API in China, Qianhong Bio-pharma has ranked fourth in exports in recent years. In 2014, the company's heparin API capacity amounted to 5.5 trillion units, but the annual output and sales volume only reached about 2 trillion units based on market considerations. In 2015, the company was granted with a drug registration approval on enoxaparin sodium API and preparations; its dalteparin passed the inspection by CFDA; its nadroparin API and preparations were recognized by new drug review in December, and will go into the production inspection stage. Besides, the company's ongoing heparin sodium preparation expansion project is expected to be completed in March 2016.

China Heparin Industry Report, 2015-2018 mainly deals with the followings:

Global heparin supply & demand, competitive landscape and forecast, etc.;

Policies, market situation, competitive landscape, import & export, and development forecast, etc. of China heparin industry;

Operation, Heparin Business, development prospect, etc. of 7 heparin enterprises in China.

Read the full report: http://www.reportlinker.com/p0354148-summary/view-report.html

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

Contact Clare: clare@reportlinker.com

US: (339)-368-6001

Intl: +1 339-368-6001

 


'/>"/>
SOURCE Reportlinker
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Oramed Announces Closing of Licensing and Investment Deal with HTIT for Oral Insulin Capsule in China
2. Patenting Activity in Pharma Sector Strongest in China among BRIC Nations, Finds Frost & Sullivan
3. Wins Finance Holdings Inc. Enters the Tele-medical Equipment Leasing Sector in China, Signing Seven Agreements Valued at RMB 49.5 Million (US$7.7 Million)
4. China Diabetes Market Report - Industry Review, Analysis & Forecasts 2015
5. Mauna Kea Technologies Receives New Regulatory Approval for Cellvizio 100s in China
6. Global Diabetes Care Devices Market Outlook: 2015-2020 - Asian Economic Giants (India and China) Set to Spearhead the Growth of Diabetic Care Devices Market
7. Oramed Signs up to $50 Million Licensing and Investment Agreements for Oral Insulin Capsule in China
8. Abaxis, Inc. to Place 200 Piccolo Xpress Instruments in the Peoples Republic of China
9. Medical Device Sourcing With The China Market - Who are the key Suppliers?
10. Global and China Contrast Media / Contrast Agent Market Projections for 2015 - 2020
11. Fiagon AG gains a strong strategic partner from China - Donghai Securities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... ... February 19, 2020 , ... A new study released today ... clusters throughout the damaged site of a compressed spinal cord. It is also the ... vector to target the oxygen-deprived sites enhances the injured spinal cord’s recovery. , ...
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... The Team ... equal access to medicine for everyone affected by diabetes, announced a partnership with VeloCity, ... , The third annual VeloCity event takes place on May 2nd and begins ...
(Date:2/16/2020)... , ... February 16, 2020 , ... In Partnership with ... free dental services at its Kennewick, WA office. , A limited number of appointments ... to schedule beforehand. For more information or to schedule an appointment, please call (509)-820-4302. ...
Breaking Medicine Technology:
(Date:2/20/2020)... ... 2020 , ... Millennial women are flocking to cosmetic surgeons like Dr. Richard ... treatments to achieve “ Rich Girl Face .” In fact, Glamour magazine called it ... into 2020. It’s a look inspired by the signature bee-stung lips, smooth skin, lifted ...
(Date:2/19/2020)... ST. LOUIS (PRWEB) , ... February 19, 2020 ... ... announced the availability of and application deadline for its new Lifestyle Medicine Residency ... curriculum designed for integrated implementation into medical residency programs. Driven by resident ...
(Date:2/19/2020)... ... February 19, 2020 , ... BPM+ Health , a ... it will participate in the HIMSS20 Global Health Conference & Exhibition, ... professionals and other stakeholders at HIMSS20 – the largest global health information and ...
(Date:2/16/2020)... ... February 16, 2020 , ... Accumen Inc., the leader ... AABB and The Joint Commission to provide a complimentary series of Patient Blood ... coordinators and transfusion safety officers) within U.S. hospitals. , “Accumen’s mission ...
(Date:2/15/2020)... ... ... It all started back in 2010, when Jennifer Martinez (Founder) was delighted ... was on to something special. The Heartsters have now become a circle of ... health condition or illness, a disability or just having a bad day. , ...
Breaking Medicine News(10 mins):